TrialBlood advances2018

Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine.

Andrew C Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.